Proteomic Biomarkers Are Predictive of Non-Relapse Mortality in Patients Treated With Post-Transplantation Cyclophosphamide Following HLA-Haploidentical or HLA-Matched-Related or –Unrelated Allogeneic BMT
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2015.11.803
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2016
Authors
Publisher
Elsevier BV